17.5006  -0.281 (-1.58%)		01-08 11:36
Open: 17.61 High: 17.61 Volume: 429		Pre. Close: 17.7812 Low: 17.5006 Market Cap: 3(M)

Short term
Mid term
Targets	6-month :	21.18	1-year :	24.74
Resists	First :	18.13	Second :	21.18
Pivot price	17.4
Supports	First :	17.31	Second :	16.8
MAs	MA(5) :	17.28	MA(20) :	17.45
	MA(100) :	16.35	MA(250) :	14.68
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	54	D(3) :	35.8
RSI	RSI(14): 55
52-week	High :	18.13	Low :	11.19

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ WDNA ] has closed below upper band by 39.4%. Bollinger Bands are 11% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	17.63 - 17.72	17.72 - 17.8
Low:	17.33 - 17.43	17.43 - 17.52
Close:	17.41 - 17.59	17.59 - 17.75

The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Tue, 06 Jan 2026
Responsive Playbooks and the WDNA Inflection - Stock Traders Daily

Thu, 01 Jan 2026
WisdomTree BioRevolution Fund (BATS:WDNA) Shares Up 27.2% – Still a Buy? - Defense World

Fri, 26 Dec 2025
(WDNA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Wed, 24 Dec 2025
WISDOMTREE BIOREVOLUTION FUND To Go Ex-Dividend On December 26th, 2025 With 0.77052 USD Dividend Per Share - 富途牛牛

Tue, 22 Jul 2025
Beyond The Buzz - Segmenting AI Exposure - Seeking Alpha

Wed, 06 Dec 2023
Wager on WDNA for Biotech Rebound - ETF Trends

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: CBOE
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.